GHK-Cu suppresses inflammation through multiple signaling pathway interventions, reducing production of pro-inflammatory cytokines like TNF-alpha and IL-6 while decreasing inflammatory cell infiltration into tissues
In 1999, in a notable discovery, the endogenous ligand of the centrally localized GHS-R1a was identified in peripheral tissue (Kojima et al., 1999)
When to Contact Us (Seek Medical Advice if You Experience): Fever of 100.4F (38C) or higher Blistering at the injection site Muscle aches, nausea, dizziness, or headache Skin rash, severe itching, vomiting, or hives TIPS TO REDUCE SIDE EFFECTS BOOK NOW Rotate Injection Sites: Alternate injection areas to prevent irritation
Designed strictly for research, the kit allows controlled investigation into solution stability, dispersion, and experimental outcomes
Positioning in the market
International Journal of Cosmetic Science